A Study to Evaluate the Efficacy and Safety of SC0062 in the Treatment of Chronic Kidney Disease
A Randomized, Double Blind, Placebo Parallel Controlled, 2 Cohorts, Multicenter Phase II Study to Investigate the Safety and Efficacy of SC0062 Capsule in Patients With Chronic Kidney Disease With Albuminuria A Randomized, Double Blind, Placebo Parallel Controlled, 2 Cohorts, Multicenter Phase II Study to In ...
Diabetic Kidney Disease;IgA Nephropathy
Drug: Placebo of SC0062;Drug: SC0062 low dose;Drug: SC0062 medium dose;Drug: SC0062 high dose